Journal: Frontiers in Microbiology
Article Title: Emergence and characterization of a novel ST627-KL8 carbapenem-resistant Klebsiella pneumoniae lineage associated with ICU transmission in a tertiary hospital, China
doi: 10.3389/fmicb.2025.1723336
Figure Lengend Snippet: The mucoviscosity (A) , capsule quantification (B) , and serum resistance (C) of ST627-KL8 strains. (A) Mucoviscosity in three ST627-KL8 clinical strains, K. pneumoniae ATCC 43816 and K. pneumoniae ATCC 700603. The mucoviscosity of strains was determined by a semi-quantitative measurement. (B) Capsule uronic acid production in three ST627-KL8 clinical strains, K. pneumoniae ATCC 43816 and K. pneumoniae ATCC 700603. (C) The resistance of strains against human serum. The serum killing assays were performed by incubating three ST627-KL8 isolates, K. pneumoniae ATCC 43816 and K. pneumoniae ATCC 700603, with human serum for 1, 2, or 3 h at 37°C. Data are presented as mean ± SD derived from three separate experiments. One-way ANOVA with Dunnett’s test was used to analyze data, **** p < 0.0001. For panel (C) , **** p < 0.0001 and *** p < 0.001 indicated ST627-KL8 versus K. pneumoniae ATCC 43816, #### p < 0.0001 and ### p < 0.001 for ST627-KL8 versus K. pneumoniae ATCC 700603.
Article Snippet: In the Galleria mellonella model, ST627-KL8 exhibited intermediate virulence (66.7%–76.7% survival), between the hypervirulent K. pneumoniae ATCC 43816 strain (30.0%) and the low-virulence K. pneumoniae ATCC 700603 strain (96.7%).
Techniques: Derivative Assay